GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (FRA:HIGH) » Definitions » Price-to-Owner-Earnings

Cantourage Group SE (FRA:HIGH) Price-to-Owner-Earnings : (As of Jun. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Price-to-Owner-Earnings?

As of today (2024-06-09), Cantourage Group SE's share price is €6.40. Cantourage Group SE does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cantourage Group SE's Price-to-Owner-Earnings or its related term are showing as below:


FRA:HIGH's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.31
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-09), Cantourage Group SE's share price is €6.40. Cantourage Group SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00. Therefore, Cantourage Group SE's PE Ratio for today is N/A.

As of today (2024-06-09), Cantourage Group SE's share price is €6.40. Cantourage Group SE's EPS without NRI for the trailing twelve months (TTM) ended in was €0.00. Therefore, Cantourage Group SE's PE Ratio without NRI for today is N/A.


Cantourage Group SE Price-to-Owner-Earnings Historical Data

The historical data trend for Cantourage Group SE's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Price-to-Owner-Earnings Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Price-to-Owner-Earnings falls into.



Cantourage Group SE Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cantourage Group SE's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=6.40/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (FRA:HIGH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cantourage Group SE Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (FRA:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (FRA:HIGH) Headlines